/other/Spermosens_AB_publ-logo.jpg?Expires=1750131544&Signature=ok7gf-kqpR9gPvYPzqMylWq1c7JwZVmZ4AM3cqXk8WGDeKXW2V7Wkp7cH~cFBlWTX4GiZKsi4MOQEfu8bygLIOtB0LgcEy1UnyjluEuNsHR-UPQibwu5WuhJcyi27qxhGzhXaPFUKXUEVQNLkRbObec7q7M03Gs0xS1FlWqxIWkvi4nNArakfekM8AMTpJ5U4w1l4Zv4I8Qj7HuXVlO4D821hAb6rCo331hVMV2rZQhqS33UtTL2VDbpUR5YpNyvcAuSiXlFAaUWcIgoBSa-cDMvQui5q2D~ci4fukcKPv7BOY8dBP8G4xXLVhxf0ziGLSXaqB5RBMBKM9j6adj7Ew__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
Spermosens AB (publ)
SPERM | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0015346424 (+6 more)
- LEI:
- 549300OM4P4VB7T8RN09
- Country:
- Sweden
- Address:
- Medicon Village, 223 81 Lund
- Website:
- https://spermosens.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Spermosens are active in medical technology. The company specializes in the development of medical devices. The product portfolio is broad and includes products for male infertility and individually tailored fertility treatments. Research and development is conducted via its own technological platform that analyzes sperm quality, which is further used for medical data and potential fertilization. The largest operations are in the Nordic market.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
European Institute of Science AB | Sweden | EURI B | |
|
European Medical Solutions | Belgium | ALEMS | |
|
Evogene Ltd. | Israel | EVGN | |
|
Evolva Holding SA | Switzerland | EVE | |
|
EXACT Therapeutics AS | Norway | EXTX | |
|
Exosens | France | EXENS | |
|
ExpreS2ion Biotech Holding AB | Sweden | EXPRS2 | |
|
Fermentalg | France | ALGAE | |
|
Formycon AG | Germany | FYB | |
|
FRONTIER IP GROUP PLC | United Kingdom | FIPP |